DBI was founded as a spin-off of USZ/UKBB and ETH in 2018 with the vision to uncover the full potential of Molecular Breath Analysis to advance precision medicine and make it available for general health care. The core competences are in patterned analytical analysis of data with highest accuracy.
DBI was founded as a spin-off of USZ/UKBB and ETH in 2018 with the vision to uncover the full potential of Molecular Breath Analysis to advance precision medicine and make it available for general health care. The core competences are in patterned analytical analysis of data with highest accuracy.
DBI was founded as a spin-off of USZ/UKBB and ETH in 2018 with the vision to uncover the full potential of Molecular Breath Analysis to advance precision medicine and make it available for general health care. The core competences are in patterned analytical analysis of data with highest accuracy.
Rapid biochemical test for diagnosing strokes with occlusion of large vessels
FONGIT Innovation Fund is a financing tool resulting from the collaboration between FONGIT and the State of Geneva.
FONGIT Innovation Fund is a financing tool resulting from the collaboration between FONGIT and the State of Geneva.
ABCDx is a company headquartered in Geneva, Switzerland that seeks and develops diagnostic tools with innovative blood-based biomarkers for acute brain injuries such as trauma and stroke.
FONGIT Innovation Fund is a financing tool resulting from the collaboration between FONGIT and the State of Geneva.
Rapid biochemical test for diagnosing strokes with occlusion of large vessels